SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-181098
Filing Date
2020-06-26
Accepted
2020-06-26 17:03:50
Documents
13
Period of Report
2020-06-22
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d948326d8k.htm   iXBRL 8-K 48689
  Complete submission text file 0001193125-20-181098.txt   215785

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA pfe-20200622.xsd EX-101.SCH 4524
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pfe-20200622_def.xml EX-101.DEF 13708
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pfe-20200622_lab.xml EX-101.LAB 22717
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pfe-20200622_pre.xml EX-101.PRE 14676
9 EXTRACTED XBRL INSTANCE DOCUMENT d948326d8k_htm.xml XML 6258
Mailing Address 235 E 42ND ST NEW YORK NY 10017
Business Address 235 E 42ND ST NEW YORK NY 10017 2125732323
PFIZER INC (Filer) CIK: 0000078003 (see all company filings)

IRS No.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-03619 | Film No.: 20994910
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences